Tool: DupCheckTool: DupCheck is a web-based tool toscreen forduplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.

Project FlyerProject Flyer

Click here to download 
the NEWMEDS project flyer! 

consortium teaser

Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms

IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations


NEWMEDS is funded by the Innovative Medicines Initiative, a unique large scale public-private partnership between the European Union (represented by the European Commission) and the pharmaceutical industry (represented by the European Federation of Pharmaceutical Industries and Associations, EFPIA).
IMI aims to put Europe at the forefront of biopharmaceutical innovation and to support more efficient discovery and development of better medicines for patients.
IMI's innovative funding scheme has a budget of 1 billion contributed by the European Union's Seventh Framework Programme (FP7/2007-2013). That amount will be matched by in kind contributions worth at least another 1 billion euro from the EFPIA member companies.